Stem cell therapy for relapsing MS proves effective and safe, study finds

An experimental stem cell therapy proved effective and safe in patients with a relapsing form of ...

Posted: Jan 15, 2019 5:04 PM
Updated: Jan 15, 2019 5:04 PM

An experimental stem cell therapy proved effective and safe in patients with a relapsing form of multiple sclerosis (MS), an autoimmune disease that affects the central nervous system, new research finds.

A stem cell transplant using a lower-dose regimen of chemotherapy plus immune system suppressors is more effective at preventing disease progression compared to currently used disease-modifying therapies, according to the new study published Tuesday in the journal JAMA. (The stem cell treatment is known as "autologous hematopoietic stem cell transplantation" or HSCT.)

Autoimmune disorders

Biology

Biotechnology

Business and industry sectors

Business, economy and trade

Chronic diseases

Diseases and disorders

Health and medical

Immune system disorders

Medical biotechnology

Medical fields and specialties

Medical research

Multiple sclerosis

Pharmaceuticals

Psychology

Science

Stem cells

"I never use the word 'cure' -- never," said Dr. Richard K. Burt, lead author of the study and chief of Immunotherapy and Autoimmune Diseases at Northwestern University Feinberg School of Medicine in Chicago. However, only a minority of patients receiving HSCT relapse by the five year mark, he said. "The vast majority don't."

How does this experimental stem cell therapy work?

HSCT essentially reboots the immune system.

"Out with the old, in with the new" is the goal, said Burt, adding that it is a "one-time treatment. You're done, you're off drugs." First a patient's blood stem cells are collected and then the patient is treated with chemotherapy drugs. Then, blood stem cells are returned to the patient to jump start the development of a new immune system.

In contrast, disease-modifying therapies work differently. These are a dozen or more drugs designed to be chronic, continuous treatment that targets and modulates the immune system.

The new comparison study took place at medical centers in the US, UK, Sweden and Brazil, where 110 patients with relapsing-remitting MS participated in the randomized clinical trial, a gold standard medical test. Patients received either the HSCT protocol or a different class of disease-modifying therapy than they'd previously used.

HSCT proved to be the more effective treatment: Of 55 patients receiving HSCT, only three patients showed disease progression at one year, the study showed. Yet, 34 of 55 patients in the disease-modifying therapy group showed disease progression at one year. Disease progression was measured using the Expanded Disability Status Scale, a method for monitoring changes in symptoms over time.

Among the HSCT group, the proportion of patients with disease progression was (roughly) 2% up to two years, 5% at three years, and 10% at 4 and 5 years. Meanwhile, the proportion of patients with no evidence of disease -- defined as no progression, no relapses, and no new or enlarging lesions on MRI scans -- was (nearly) 98% at one year, 93% at two years, 90% at three years, and 78% at four and five years.

By contrast, almost one quarter of the patients in the disease-modifying therapy group showed disease progression at one year, more than half at two years, and just under three-quarters at five years. And the proportion of patients with no evidence of disease was (about) 40% at six months, 21% at one year and 3% by years four and five.

What are the side effects of HSCT?

Side effects of HSCT can include infertility, said Burt, who noted that women can choose to preserve their eggs before treatment. And some patients developed autoimmune thyroid disease, a treatable condition. He noted that the disease-modifying treatments also have side effects.

Bruce Bebo, executive vice president of research at the National MS Society, said the study is "too small to really be definitive, but it does add to a growing amount of evidence that suggests this approach has benefits."

The disease-modifying treatments tested in the study did not include two of the most recent and most effective drugs. "It is a gap in our knowledge," said Bebo, who was not involved in the research. "We didn't have [them] when the study started."

In past studies of HSCT, patients with progressive MS did not respond to the therapy, noted Bebo. About 85% of patients are diagnosed with relapsing-remitting multiple sclerosis, where attacks of symptoms -- such as dizziness, pain, and blurred vision -- are followed by periods of remission. Yet, a "substantial portion" of relapsing MS patients evolve to develop progressive MS, where symptoms no longer wax and wane and instead worsen over time, explained Bebo.

"In the early days, HSCT was also riskier than it is now. Protocols have been fine-tuned since the early days," said Bebo, who said some past patients died. Today, the risk of mortality is "really, really low," said Bebo, who added that the chemotherapy drugs used by Burt "have been used to treat blood cancers for many many years."

Ultimately, HSCT could be a beneficial treatment for some patients with MS, said Bebo: "Probably people with an aggressive form of the disease who are not responding to other types of therapy."

Bebo advises patients to "be really cautious about a facility advertising stem cell treatment for MS." Other experimental stem cell approaches are "less mature" and less studied, he said, and they may endanger a patient's health.

Burt said, "This should be done in a major university medical center." Bebo added that "you have to make sure it's being done by a center with a great deal of experience. You really have to do your homework and find a place that has a published track record."

Going forward, Burt will fine tune HSCT to make it safer.

"The hope is to change the natural history of this disease," said Burt. "This data suggests we're doing it."

Indiana Coronavirus Cases

Data is updated nightly.

Confirmed Cases: 50300

Reported Deaths: 2748
CountyConfirmedDeaths
Marion11920692
Lake5432248
Elkhart347058
Allen2902133
St. Joseph205169
Hamilton1665101
Cass16449
Hendricks1446100
Johnson1325118
Porter80238
Tippecanoe7599
Clark68144
Vanderburgh6816
Madison67264
LaPorte60527
Howard59458
Bartholomew59345
Kosciusko5704
Marshall5308
Noble50128
LaGrange4829
Jackson4783
Boone47444
Delaware46952
Hancock46036
Shelby43525
Floyd40444
Morgan33631
Monroe32928
Grant30926
Dubois2976
Henry29717
Montgomery29720
Clinton2893
White26810
Decatur25532
Dearborn25423
Lawrence25225
Vigo2478
Warrick24329
Harrison21722
Greene19332
Miami1922
Jennings17912
Putnam1728
DeKalb1674
Scott1639
Wayne1536
Daviess15017
Perry1459
Orange13723
Steuben1362
Jasper1332
Franklin1278
Ripley1277
Wabash1152
Carroll1132
Gibson1132
Fayette1057
Whitley1045
Newton10010
Starke983
Huntington932
Randolph794
Wells791
Jefferson782
Fulton731
Jay680
Washington681
Knox670
Clay665
Pulaski661
Rush613
Posey550
Owen521
Benton510
Spencer501
Adams491
Sullivan471
Brown431
Blackford402
Fountain352
Crawford330
Tipton321
Switzerland300
Martin240
Parke230
Ohio220
Vermillion200
Warren151
Union130
Pike110
Unassigned0193

Ohio Coronavirus Cases

Data is updated nightly.

Confirmed Cases: 62856

Reported Deaths: 3032
CountyConfirmedDeaths
Franklin11433443
Cuyahoga8786393
Hamilton6563207
Lucas2889305
Marion274039
Montgomery237835
Summit2299209
Pickaway221641
Mahoning1907239
Butler176747
Columbiana135060
Stark1196114
Lorain109769
Trumbull103277
Warren94525
Clark79310
Delaware67515
Fairfield64317
Tuscarawas60110
Lake57022
Belmont56722
Medina56632
Licking56012
Miami50331
Portage48759
Wood47451
Clermont4537
Ashtabula44544
Geauga42543
Wayne37253
Richland3635
Allen34841
Greene3229
Mercer29510
Erie26722
Holmes2575
Darke25326
Huron2382
Madison2139
Ottawa16624
Sandusky15715
Washington14420
Coshocton1413
Ross1393
Crawford1385
Putnam13415
Hardin12312
Morrow1211
Athens1111
Auglaize1094
Jefferson1052
Muskingum961
Union931
Monroe8917
Hancock851
Lawrence820
Preble821
Hocking809
Clinton791
Guernsey793
Shelby744
Williams742
Logan681
Fulton660
Scioto650
Carroll643
Ashland632
Wyandot625
Brown601
Fayette550
Defiance533
Knox531
Champaign511
Highland491
Van Wert451
Perry411
Seneca402
Henry330
Paulding280
Jackson270
Pike270
Adams251
Vinton232
Gallia201
Noble130
Harrison121
Meigs120
Morgan120
Unassigned00
Fort Wayne
Clear
70° wxIcon
Hi: 86° Lo: 64°
Feels Like: 70°
Angola
Clear
66° wxIcon
Hi: 82° Lo: 62°
Feels Like: 66°
Huntington
69° wxIcon
Hi: 86° Lo: 64°
Feels Like: 69°
Decatur
Clear
70° wxIcon
Hi: 85° Lo: 65°
Feels Like: 70°
Van Wert
Clear
70° wxIcon
Hi: 86° Lo: 64°
Feels Like: 70°
Sunday starts wet, ends dry
WFFT Radar
WFFT Temperatures
WFFT National

Community Events